Godlike Productions - Reply to Thread

Users Online Now: 930 (Who's On?)	Visitors Today: 140,183
Pageviews Today: 233,471	Threads Today: 89	Posts Today: 1,511
03:06 AM

REPLY TO THREAD

Subject Regeneron Drug Cocktail Cuts Covid Hospitalization and Death 70%

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message Regeneron Pharmaceuticals announced Tuesday that its COVID-19 antibody treatment has proven in a clinical study to sharply reduce the risk of hospitalization or death among patients who test positive for the virus.

The company announced on its website that a trial involving more than 4,500 patients indicated that Regeneron's treatment reduced both risks by 70 percent.

The drug cocktail was also effective in shortening recovery time from two weeks to 10 days, according to the company's findings.

All of the 4,567 patients involved in Regeneron's study had at least one risk factor that put them at a heightened risk of hospitalization or death from the disease, such as obesity or heart conditions, according to the company's website.

[link to thehill.com (secure)]

Pictures (click to insert)





\| Next Page >>